News
Infective endocarditis from IV drug use tied to hemorrhagic stroke
April 27, 2021
The incidence of patients with IVDU-associated endocarditis increased 630% from 2014 to 2018.
![1]()
News
Efficacy and safety of daily low-dose colchicine after recent MI
April 26, 2021
Can giving low-dose colchicine to patients after a recent myocardial infarction reduce future ischemic cardiovascular events, compared with placebo?
![1]()
News
Lower target LDL-C cuts risk of CV events in ischemic stroke patients
April 23, 2021
Is a target LDL cholesterol (LDL-C) level of less than 70 mg/dL superior to a target LDL-C level of 90-110 mg/dL in prevention of future cardiovascular (CV) events in patients with a prior stroke of atherosclerotic origin or transient ischemic attack (TIA)?
![1]()
News
COVID plus MI confers poor prognosis; 1 in 3 die in hospital
April 22, 2021
National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.
![1]()
News
Assessing the efficacy and safety of dapagliflozin in patients with HFrEF
April 22, 2021
Can the use of dapagliflozin, in addition to guideline-directed medical therapy, improve patient-reported outcomes and health-related quality of life in patients with heart failure and reduced ejection fraction (HFrEF)?
![1]()
News
Pneumonia risk soars in heart failure patients, especially HFpEF
April 19, 2021
An analysis of two large trials found that patients with heart failure have an elevated risk of pneumonia and related adverse cardiovascular events.
![1]()
News
How often should we check EKGs in patients starting antipsychotic medications?
April 19, 2021
A prolonged QT interval can predispose a patient to dangerous arrhythmias that can result in sudden cardiac death.
News
How some COVID-19 vaccines could cause rare blood clots
April 14, 2021
Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.
![1]()
News
Arthritis drug may curb myocardial damage in acute STEMI
April 13, 2021
Tocilizumab appears to improve myocardial salvage by helping tamp down the inflammatory overshoot that occurs during infarction and reperfusion.
News
More evidence MIS-C is a delayed response to SARS-CoV-2
April 13, 2021
CDC analysis of the largest cohort of MIS-C cases in the United States to date shows three temporal peaks of diagnoses in the United States and further validates the “prevailing hypothesis that MIS-C is a postinfectious mediated disorder.”
